Discovery of potent and effective inhibitors containing sulfoxide structures targeting EML4-ALK rearrangement and EGFR mutant non-small cell lung cancer-Reference-Cited by-同舟云学术

Discovery of potent and effective inhibitors containing sulfoxide structures targeting EML4-ALK rearrangement and EGFR mutant non-small cell lung cancer

Published:2023-09 Issue: Volume:138 Page:106653
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

An Baijiao,Fan Yangyang,Li Wei,Nie Wenyan,Nie Haoran,Wang Mengxuan,Feng Jie,Yao Han,Zhang Yin,Li Xingshu,Tian Geng

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference41 articles.

1. Cell-cell contact and receptor tyrosine kinase signaling;MacKenzie;CSH Perspect. Biol.,2018

2. Mechanisms of receptor tyrosine kinase activation in cancer;Du;Mol. Cancer,2018

3. Role of receptor tyrosine kinases mediated signal transduction pathways in tumor growth and angiogenesis—new insight and futuristic vision;Huang;Int. J. Biol. Macromol.,2021

4. Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance;Schram;Nat. Rev. Clin. Oncol.,2017

5. Cancer statistics, 2022;Siegel;CA-Cancer J. Clin.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Perspectives in the Development of Novel EGFR Inhibitors for the Treatment of NSCLC;Mini-Reviews in Medicinal Chemistry;2024-10

2. A novel c-Met/TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation;Cell Death & Disease;2023-11-09

3. Anaplastic lymphoma kinase inhibitors—a review of anticancer properties, clinical efficacy, and resistance mechanisms;Frontiers in Pharmacology;2023-10-25